Renin-angiotensin system-regulating aminopeptidases in tumor growth of rat C6 gliomas implanted at the subcutaneous region

Anticancer Research

Volumn 32, Issue 9, 2012, Pages 3675-3682

  Mayas Torres, Maria Dolores ^a   Rámirez Éxposito, María Jeśus ^a   Carrera, María Pilar ^a   Cobo, Manuela ^b   Mart́inez Martos, José Manuel ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b University Hospital of Jaen   (Spain)

Author keywords

Aminopeptidase; C6 glioma; Renin angiotensin system; Tumor growth

Indexed keywords

2 NAPHTHYLAMINE; AMINOPEPTIDASE; ASPARTYL AMINOPEPTIDASE; BIOLOGICAL MARKER; GLUTAMYL AMINOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; ENZYME REGULATION; ENZYME SUBSTRATE; FLUOROMETRY; GLIOMA; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TUMOR GROWTH; TUMOR VOLUME;

AMINOPEPTIDASES; ANIMALS; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; GLIOMA; MALE; NEOPLASM TRANSPLANTATION; RAS PROTEINS; RATS; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM;

EID: 84867029125     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. De Angelis LM: Brain tumors. N Engl Med 2: 114-123, 2001.
2. Mahaley MSJ, Mettlin C, Natarajan N, Laws ERJ and Peace BB: National survey of patterns of care for brain tumor patients. J Neurosurg 71: 826-836, 1989. (Pubitemid 20008561)
3. Parsa AT, Chakrabarti I, Patrick T, Chi JH, Hall JS, Kaiser MG and Brucer JN: Limitations of the C6/Wistar rat intracerebral glioma model: Implications for evaluating immunotherapy. Neurosurgery 47: 993-1000, 2000. (Pubitemid 32103680)
4. Benda P, Lightbody J, Sato G, Levine L and Sweet W: Differentiated rat glial cell strain in issue culture. Science 161: 370-371, 1968.
5. Peterson DL, Sheridan PJ and Brown WE: Animal models for brain tumors: Historical perspectives and future directions. J Neurosurg 80: 865-876, 1994. (Pubitemid 24129683)
6. Watanabe K, Sakamoto M, Somiya M, Amin MR, Kamitani H and Watanabe T: Feasibility and limitations of the rat model by C6 gliomas implanted at the subcutaneous region. Neurological Res 24: 485-490, 2002. (Pubitemid 34742684)
7. Wang D, Huang HJ, Kazlauskas A and Cavenee WK: Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res 59: 1464-1472, 1999. (Pubitemid 29160112)
8. Jensen RL: Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg Neurol 49: 189-195: 1998.
9. Schmidt NO, Westphal M, Hagel C, Ergün S, Stavrou D, Rosen EM and Lamszus K: Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 84: 10-18, 1999. (Pubitemid 29059101)
10. Arrieta O, Guevara P, Reyes S, Ortiz A, Rembao D and Sotelo J: Protamine inhibits angiogesesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine. Eur J Cancer 34: 2101-2106, 1998. (Pubitemid 28546949)
11. Zetter BR: Angiogenesis and tumor metastasis. Annu Rev Med 49: 407-24, 1998.
12. Juillerat-Jeanneret L, Lohm S, Hamou MF and Pinet F: Regulation of aminopeptidase A in human brain tumor vasculature: Evidence for a role of transforming growth factor beta. Lab Invest 80: 973-980, 2000. (Pubitemid 30421813)
13. Andrade SP, Cardoso CC, Machado RDP and Beraldo WT: Angiotensin-Il- induced angiogenesis in sponge implant in mice. Int J Microcirc Clin Exp 16: 302-307, 1996.
14. Fernandez LA, Twickler J and Mead A: Neovascularization produced by angiotensin II. J Lab Clin Med 105: 141-145, 1985. (Pubitemid 15036929)
15. Chansel D and Ardaillou R: Active metabolites derived from angiotensin II. Nephrologie 19: 427-432, 1998.
16. Ramírez-Expósito MJ, Garcia MJ, Mayas MD, Ramírez M and Martínez-Martos JM: Differential effects of dietary cholesterol on aminopeptidase A, B and M in the frontal cortex of male and female mice. Nutr Neurosci 4: 461-468, 2001.
17. Mayas MD, Ramírez-Exposito MJ, Garcia MJ, Ramírez M and Martínez-Martos JM: Ethanol modifies differently aspartyl- and glutamyl-aminopeptidase activities in mouse frontal cortex synaptosomes. Brain Res Bull 57: 195-203, 2002. (Pubitemid 34155393)
18. Beynon R and Bond JS: Proteolityc Enzymes, 2nd edition. Oxford University Press, New York, 2001.
19. Ueda H, Nakajima H, Hori Y, Fujita T, Nishimura M, Goto T and Okuhara M FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968. I. Taxonomy, fermentation, isolation, physic-chemical and biological properties and antitumor activity. J Antibiot 47: 301-310, 1994. (Pubitemid 24106520)
20. Carrera MP, Ramirez-Exposito MJ, Valenzuela MT, Garcia MJ, Mayas MD and Martinez-Martos JM: Glutamyl- but not aspartyl-aminopeptidase activity is modified in serum of N-methylnitrosourea- induced rat mammary tumours. Anticancer Res 24: 801-805, 2004. (Pubitemid 38625025)
21. Carrera MP, Ramirez-Exposito MJ, Valenzuela MT, Dueñas B, García MJ, Mayas MD and Martinez-Martos JM: Reninangiotensin system-regulating aminopeptidase activities are modified in the pineal gland of rats with breast cancer induced by N-methyl-nitrosourea. Cancer Invest 24: 149-153, 2006.
22. Garcia MJ, Martinez-Martos JM, Mayas MD, Carrera MP and Ramirez-Exposito MJ: Hormonal status modifies reninangiotensin system-regulating aminopeptidases and vasopressin degrading activity in the hypothalamus-pituitary-adrenal axis of male mice. Life Sci 73: 525-538, 2003. (Pubitemid 36589034)
23. Sim MK, Choo MH and Qiu XS: Degradation of angiotensin I to [des Asp I] angiotensin I by a novel aminopeptidase in the rat hypothalamus. Biochem Pharmacol 48: 1043-1046, 1994. (Pubitemid 24285183)
24. Kambayashi Y, Bardan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T and Inagami T: Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268: 24543-24546, 1993. (Pubitemid 23335457)
25. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE and Dzau VJ: Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 268: 24539-24542, 1993. (Pubitemid 23335456)
26. Ganong WF: The brain renin-angiotensin system. Annu Rev Physiol 46: 17-31, 1984.
27. Milsted A, Barna BP, Ransohoff RM, Brosnihan KB and Ferrario CM: Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc Natl Acad Sci USA 87: 5720-5723, 1990.
28. Morimoto S, Cassell MD and Sigmund CD: Glia- and neuronspecific expression of the renin-angiotensin system in brain alters blood pressure, water intake, and salt preference. J Biol Chem 277: 33235-33241, 2002. (Pubitemid 34984843)
29. Escobar E, Rodriguez-Reyna T, Arrieta O and Sotelo J: Angiotensin II, cell proliferation and angiogenesis regulator: Biologic and therapeutic implications in cancer. Curr Vasc Pharmacol 2: 385-399, 2004. (Pubitemid 39200189)
30. Rivera E, Arrieta O, Guevara P, Duarte-Rojo A and Sotelo J: AT1 receptor is present in glioma cells, its blockage reduces the growth of rat glioma. Br J Cancer 85: 1396-1399, 2001. (Pubitemid 33081938)
31. Juillerat-Jeanneret L, Celerier J, Chapuis Bernasconi C, Nguyen G, Wostl W, Maerki HP, Janzer RC, Corvol P and Gasc JM: Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br J Cancer 90: 1059-1068, 2004. (Pubitemid 38495829)
32. Arrieta O, Pineda-Olivera B, Guevara-Salazar P, Hernández- Pedro N, Morales-Espinosa D, Cerón-Lizarraga TL, Gonzálezde la Rosa CH, Rembao D, Segura-Pacheco B and Sotelo J: Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis. Br J Cancer 99: 160-166, 2008.
33. Marchio S, Lahdenranta J, Schlingemann RO, Valdembri D, Wesseling P, Arap MA, Hajitou A, Ozawa MG, Trepel M, Giordano RJ, Nanus DM, Dijkman HB, Oosterwijk E, Sidman RL, Cooper MD, Bussolino F, Pasqualini R and Arap W: Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell 5: 151-162, 2004. (Pubitemid 38283801)
34. Fujimura H, Ino K, Nagasaka T, Nakashima N, Nakazato H, Kikkawa F and Mizutani S: Aminopeptidase A expression in cervical neoplasia and its relationship to neoplastic transformation and progression. Oncology 58: 342-352, 2000. (Pubitemid 30265345)
35. Teranishi J, Ishiguro H, Hoshino K, Noguchi K, Kubota Y and Uemura H: Evaluation of role of angiotensin III and aminopeptidases in prostate cancer cells. Prostate 68: 1666-1673, 2008.
36. Dixon J, Kaklamanis L, Turley H, Hickson ID, Leek RD, Harris AL and Gatter KC: Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol 47: 43-47, 1994. (Pubitemid 24057748)
37. Varona A, Blanco L, Lopez JI, Gil J, Agirregoitia E, Irazusta J and Larrinaga G: Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma. Am J Physiol Renal Physiol 292: F780-F788, 2007. (Pubitemid 46220546)
38. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T and Azuma I: Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 54: 137-143, 1993. (Pubitemid 23137011)
39. Tamarat R, Silvestre JS, Durie M and Levy BI: Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 82: 747-756, 2002. (Pubitemid 34633824)
40. Cook JL, Giardina JF, Zhang Z and Re R: Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells. J Mol Cell Cardiol 34: 1525-1537, 2002. (Pubitemid 35373675)
41. Fujiyama S, Matsubara H, Nozawa Y, Maruyama K, Mori Y, Tsutsumi Y, Masaki H, Uchiyama Y, Koyama Y, Nose A, Iba O, Tateishi E, Ogata N, Jyo N, Higashiyama S and Iwasaka T: Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 88: 22-29, 2001. (Pubitemid 32064078)
42. Arrieta O, Guevara P, Escobar E, Garcia-Navarrete R, Pineda B and Sotelo J: Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br J Cancer 92: 1247-1257, 2005.
43. Ardaillou R and Chansel D: Synthesis and effects of active fragments of angiotensin II. Kidney Int 52: 1458-1468, 1997. (Pubitemid 28032049)
44. Zini S, Fournie-Zaluski MC, Chauvel E, Roques BP, Corvol P and LLorens-Cortes C: Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: Predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 93: 11968-11973, 1996.
45. Harding JW and Felix D: Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III. Brain Res 410: 130-134, 1987. (Pubitemid 17075194)
46. Stoll M, Meffert S, Stroth U and Unger T: Growth or antigrowth: angiotensin and the endothelium. J Hypertens 13: 1529-1534, 1995. (Pubitemid 26015770)
47. Matsubara H: Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83: 1182-1191, 1998.
48. Brunier M: Angiotensin II type 1 receptor blockers. Circulation 103: 904-912, 2001.
49. Nahmias D and Strosberg AD: The angiotensin AT2 receptor: Searching for signal-transduction pathways and physiological function. Trends Pharmacol Sci 16: 223-225, 1995.
50. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL and Robertson JW: Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352: 179-184, 1998. (Pubitemid 28327802)